Redeye Feed

2024-04-19 11:32:00 BONESUPPORT - Leading an ongoing paradigm shift

2024-04-19 09:53:00 Vertiseit - Building to Become the Global Niche Leader

2024-04-19 09:50:00 Hansa Biopharma Q1 - Improved European launch support

2024-04-19 07:54:00 Magle Chemoswed Q1 - Expansion by acquisition

2024-04-15 13:35:00 Annexin - Continued focus on RVO study

2024-04-11 08:12:00 Transtema - Q1 Preview – Tough Weather Conditions Likely to Pressure Margins

2024-04-11 08:10:00 Newbury Pharmaceuticals Q2 - A bump in the road

2024-04-03 07:32:00 Evaxion Q4 2023 - Will 2024 be a turnaround year?

2024-04-03 07:30:00 Formpipe - Q1 Preview – Increased Sales and OPEX due to FX

2024-04-02 13:45:00 Hexatronic - Q1 Preview and New Market Data

2024-04-02 08:02:00 Addnode - Q1 Preview – Slight Increases

2024-03-28 10:12:00 CombinedX - Nethouse Expanding in Västernorrland

2024-03-27 14:13:00 Fortnox - Q1 Preview and Comment on FT Article

2024-03-25 11:22:00 TH1NG - Divests its broadband customers

2024-03-25 08:19:00 Energy Save - Increased confidence in Aira partnership

2024-03-22 08:22:00 Scandinavian ChemoTech - Weathering the storm

2024-03-21 08:12:00 Flexion Mobile - Pole position in the emerging distribution market

2024-03-19 11:19:00 Artificial Solutions - Volumes are coming back

2024-03-18 08:22:00 Biovica - Commercial progress despite a quarter with modest sales

2024-03-18 08:19:00 Nepa - Turnaround completed – strengthened belief in a possible buyout

2024-03-13 18:03:00 Faron Pharmaceuticals H2 2023 - Entering a new phase

2024-03-13 12:16:00 Hanza - Efficiency Measures in Orbit One

2024-03-12 10:14:00 Speqta - Direct Share Issue Likely Sufficient to Reach Profitability

2024-03-11 16:04:00 Herantis H2 2023 - Presented positive phase I data

2024-03-11 07:55:00 ChromoGenics - Entering 2024 with the ambitious Skanska collaboration in focus

2024-03-07 08:10:00 Fantasma Games - Strong underlying performance

2024-03-06 08:02:00 Systemair - Muted growth but solid cash generation

2024-03-04 13:44:00 Lytix Q4 2023 - All Eyes on Verrica’s Phase II

2024-03-04 11:25:00 OXE Marine - Some near-term challenges

2024-03-04 11:20:00 Q-linea Q4 2023 update - Increasing commercial interest with a slow sales conversion

2024-03-04 11:17:00 Modelon - Growth set to pick up steam in 2024

2024-03-04 09:01:00 Redeye Initiates Coverage of PMD Device Solutions

2024-03-01 16:00:00 Klaria Pharma Q4 - Eyes on the prize

2024-03-01 15:55:00 Ngenic - Enters the next phase

2024-03-01 13:36:00 Saniona - Financing in place

2024-03-01 13:35:00 Fortnox - Adjusting Our Forecasts to Price Changes

2024-03-01 09:33:00 Integrum Q3 - In line and no estimate changes

2024-03-01 08:22:00 Xbrane Biopharma Q4 2023 - Navigating muddy waters

2024-03-01 08:20:00 Media and Games Invest - Rebound in sight

2024-03-01 08:18:00 Physitrack - Prioritising positive cash flow holds back topline growth

2024-03-01 08:10:00 Scandion Oncology Q4 2023 - Striving towards randomised controlled data

2024-02-29 14:40:00 Lipum Q4 report - Clinical progress and a SEK187m rights issue

2024-02-29 08:13:00 Inhalation Sciences Q4 - Rising revenues and close to break even

2024-02-29 08:11:00 Strax - Soft topline and more write-downs

2024-02-28 14:20:00 Fluoguide Q4 2023 - Bright prospects

2024-02-28 10:08:00 Alzecure Q4 - Well-positioned pipeline

2024-02-28 09:55:00 Alzinova Q4 – With wind in the sails

2024-02-28 09:50:00 Lifecare Q4 2023 - Setting the stage

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden